Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release
about
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection andTedizolid Phosphate: a Next-Generation Oxazolidinone.Successful Treatment of Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome with the Addition of LinezolidClindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infectionsHost gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin.Antibiotic efficacy is linked to bacterial cellular respiration.Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescenceNecrotizing fasciitis: pathogenesis and treatment.Therapies for necrotising fasciitis.Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.Streptococcus agalactiae toxic shock-like syndrome: two case reports and review of the literature.Invasive community-associated MRSA infections: epidemiology and antimicrobial management.Linezolid effects on bacterial toxin production and host immune response: review of the evidenceStreptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review.Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis.Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.Understanding toxic shock syndrome.Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.Group G streptococcal sepsis, septic arthritis and myositis in a patient with severe oral ulcerations.Severe invasive beta haemolytic group A streptococcal cellulitis and eyelid necrosis treated with linezolid.Cell surface hydrophobicity and adherence of a strain of group B streptococci during the post-antibiotic effect of penicillin.Streptococcal toxic shock syndrome in the intensive care unitManagement of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
P2860
Q24643277-68004DE6-804A-4409-BE11-1B6B7672C2CCQ33420646-81DACE52-1BFC-48C6-B1C9-D2F4578456CDQ33440193-BC57977C-627E-4CA8-86F5-85DE849FF488Q33558911-2F83AAB1-6250-4FA8-8816-F811A375FB62Q34565950-0C6D7945-2E4A-4541-9030-DF68A3F671D9Q34658467-742B01F0-DEE2-4914-BA53-C1E4B72A76FAQ34974840-1489D668-4CD7-40CE-A1FC-57A4195DC73FQ35758808-0E908922-4D23-46BE-AC9E-E39E96A4EAE5Q35845962-3A1BF451-E86B-43E3-BF5B-7F105D0D8FC1Q35867280-9C9B5B38-19B8-46CE-A403-DB9F1E798A68Q36140694-B8129C58-5AEC-40B9-AC47-6DE10CC6DE75Q36377217-1CE74834-6762-4621-80F8-63CF9809D59EQ36379346-07273AC1-29AD-4557-8102-967503074422Q36779701-51580A53-EB38-4378-AC49-448C6E1FB1D7Q37726602-315B0250-C96C-49F7-961B-06A1521F78D2Q37800939-271E58DC-6F9D-41A3-B161-D51E395CC32CQ38197595-F8F59A0F-6AE5-402E-9CA1-3F210CDC226DQ38200563-C9AEBA52-BCE2-4F33-97D0-0208E946F3D0Q38671478-D727D3F0-A57F-4291-AA6C-EEDB597CA6FAQ38971508-7B941E61-C60B-4C9B-A136-4798E79D1BEEQ40650612-503FCFA6-49D1-4710-BBF6-DE77E7B2FD24Q40732163-8E3C1DA0-295A-41D7-A8CC-B3085C27E5E8Q40828569-0B547A0B-642F-4A86-886C-C99C0BD937A4Q41234193-314B9FA6-4CE8-45F5-BB0E-E5C577306FC3Q41826749-FA0A78C2-8714-4E35-BDAE-69B905A976A5Q41910244-EDD91E72-2562-41A5-90DB-364E426FC16CQ42738520-ABF89CB4-0972-4528-AC1C-26C5D3AB06DEQ46350068-1BD6455B-DA94-4243-A386-4B6C3AE338D6Q58734570-DA369613-A196-48B7-BAB5-8FA0158FD48FQ59135453-6EFF1F4B-F46D-4F0A-A6A1-84454DA3F15A
P2860
Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@ast
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@en
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@nl
type
label
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@ast
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@en
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@nl
prefLabel
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@ast
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@en
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@nl
P2093
P2860
P1476
Influences of linezolid, penic ...... l pyrogenic exotoxin a release
@en
P2093
Elizabeth A Coyle
Michael J Rybak
Raymond Cha
P2860
P304
P356
10.1128/AAC.47.5.1752-1755.2003
P407
P577
2003-05-01T00:00:00Z